Acute Evaluation of the Safety of LV-LV Delays and Its Effects on Mechanical Dyssynchrony

Abbott Medical Devices1 个研究点分布在 1 个国家目标入组 73 人开始时间: 2010年2月最近更新: 2020年7月8日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Abbott Medical Devices
入组人数: 73
试验地点: 1

研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

The purpose of this study is to evaluate the effects of various LV-LV delays during multi-site left ventricular (MSLV) pacing on mechanical dyssynchrony in cardiac resynchronization therapy (CRT) patients post-implant.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Have an approved indication for a CRT implant
•Undergoing or previously received the implant of a St. Jude Medical Promote Q 3221-36 CRT-D with a Quartet Model 1458Q LV lead at participating clinical study site
•Ability to provide informed consent for study participation and be willing and able to comply with the prescribed evaluations

排除标准

•Have persistent or permanent atrial fibrillation
•Have an intrinsic heart rate of <50 beats per minute
•Have Cheyne-Stokes breathing
•Have undergone cardiac surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures
•Have had a recent CVA or TIA within 3 months prior to enrollment
•Be less than 18 years of age
•Be pregnant

研究者

发起方

Abbott Medical Devices

申办方类型

Industry

责任方

Sponsor

研究点 (1)

Loading locations...

相似试验

已完成

3 期

Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HFHeart Failure

NCT03785405Novartis Pharmaceuticals216

终止

2 期

Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative ColitisUlcerative Colitis

NCT05672199Amgen92

已完成

2 期

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS)Alagille Syndrome

NCT02047318Mirum Pharmaceuticals, Inc.19

已完成

3 期

Iressa Follow-up TrialLung CancerBreast Cancer

NCT00357734AstraZeneca14

Enrolling By Invitation

不适用

Long Term Follow-up Study of AAVAnc80-hOTOF Gene TherapyOtoferlin Gene-mediated Hearing Loss

NCT06696456Akouos, Inc.30